[HTML][HTML] Random forest algorithm for the classification of neuroimaging data in Alzheimer's disease: a systematic review
Objective: Machine learning classification has been the most important computational
development in the last years to satisfy the primary need of clinicians for automatic early …
development in the last years to satisfy the primary need of clinicians for automatic early …
Prospective biomarkers of Alzheimer's disease: A systematic review and meta-analysis
RX Li, YH Ma, L Tan, JT Yu - Ageing Research Reviews, 2022 - Elsevier
Objective Alzheimer's disease (AD) involves a series of pathological changes and some
biomarkers were reported to assist in monitoring and predicting disease progression before …
biomarkers were reported to assist in monitoring and predicting disease progression before …
Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease
CM Wischik, RT Staff, DJ Wischik… - Journal of …, 2015 - journals.sagepub.com
Background: As tau aggregation pathology correlates with clinical dementia in Alzheimer's
disease (AD), a tau aggregation inhibitor (TAI) could have therapeutic utility …
disease (AD), a tau aggregation inhibitor (TAI) could have therapeutic utility …
Natural image bases to represent neuroimaging data
Visual inspection of neuroimagery is susceptible to human eye limitations. Computerized
methods have been shown to be equally or more effective than human clinicians in …
methods have been shown to be equally or more effective than human clinicians in …
Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings
Atrophy of the medial temporal lobe, especially the hippocampus and the parahippocampal
gyrus, is considered to be the most predictive structural brain biomarker for Alzheimer's …
gyrus, is considered to be the most predictive structural brain biomarker for Alzheimer's …
Reviews: current concepts in Alzheimer's disease: a multidisciplinary review
L Minati, T Edginton… - American Journal of …, 2009 - journals.sagepub.com
This comprehensive, pedagogically-oriented review is aimed at a heterogeneous audience
representative of the allied disciplines involved in research and patient care. After a …
representative of the allied disciplines involved in research and patient care. After a …
Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment
N Mattsson, D Tosun, PS Insel, A Simonson… - Brain, 2014 - academic.oup.com
Patients with Alzheimer's disease have reduced cerebral blood flow measured by arterial
spin labelling magnetic resonance imaging, but it is unclear how this is related to amyloid-β …
spin labelling magnetic resonance imaging, but it is unclear how this is related to amyloid-β …
On the early diagnosis of Alzheimer's Disease from multimodal signals: A survey
Abstract Introduction The number of Alzheimer's Disease (AD) patients is increasing with
increased life expectancy and 115.4 million people are expected to be affected in 2050 …
increased life expectancy and 115.4 million people are expected to be affected in 2050 …
Regional homogeneity, functional connectivity and imaging markers of Alzheimer's disease: a review of resting-state fMRI studies
Resting-state functional magnetic resonance imaging (fMRI), a promising technique for
measuring brain activities during rest, has attracted much attention in the past few years. In …
measuring brain activities during rest, has attracted much attention in the past few years. In …
[HTML][HTML] Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression
M Noguchi-Shinohara, K Ono, T Hamaguchi, T Nagai… - Scientific reports, 2020 - nature.com
We conducted a randomized placebo-controlled double-blind 24-week trial using Melissa
officinalis (M. officinalis) extract richly containing rosmarinic acid (RA) on patients with mild …
officinalis (M. officinalis) extract richly containing rosmarinic acid (RA) on patients with mild …